Publication

Employment Status in the United States and Use of Long-Acting Reversible Contraception or Moderately Effective Contraception before and after the Affordable Care Act: National Survey of Family Growth 2006–2010 and 2015–2017

Downloadable Content

Persistent URL
Last modified
  • 09/19/2025
Type of Material
Authors
    Mark Lachiewicz, Emory UniversityTiffany Hailstorks, Emory UniversityVijaya Kancherla, Emory University
Language
  • English
Date
  • 2023-06-01
Publisher
  • Elsevier Inc
Publication Version
Copyright Statement
  • Published by Elsevier Inc.
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 33
Start Page
  • 102177
End Page
  • 102177
Abstract
  • Employment status has been previously associated with contraceptive use among women of reproductive age. We assessed the association between employment status and method of contraception among US women of reproductive age, before and after the implementation of the Affordable Care Act (ACA) passed in 2010. We conducted a cross-sectional study using data from the National Survey of Family Growth (NSFG): 2006–2010 survey for our pre-ACA analysis and 2015–2017 survey for post-ACA analysis. We combined the use of moderately-effective or long-acting reversible contraceptives (LARC) as the main study outcome. Multivariable logistic regression was used to estimate adjusted prevalence odds ratios (aPOR) and 95% confidence intervals (CI). Our study included 5,572 women pre-ACA and 2,340 women post-ACA. Pre-ACA, non-Hispanic white women who were employed were significantly more likely to use moderately-effective or LARC contraceptives (aPOR = 1.66; 95% CI = 1.28, 2.14), but post-ACA, this association was non-significant (aPOR = 0.94; 95% CI = 0.67, 1.33). Findings were not significant for other race/ethnic groups in either time frame. Our study shows that being employed was no longer associated with contraceptive method during a post-ACA time period among non-Hispanic white women. Modifications to the ACA should be scrutinized to further evaluate the impact it may have on women's access to moderately-effective or LARC contraception.
Author Notes
  • Mark Lachiewicz, Department of Gynecology and Obstetrics, Emory University, 101 Woodruff Circle, Suite 4208, Atlanta, GA 30322, USA. Email: mlachiewicz@gmail.com
Keywords

Tools

Relations

In Collection:

Items